U.S., Aug. 13 -- ClinicalTrials.gov registry received information related to the study (NCT07118332) titled 'Psilocybin as a Treatment for Chronic Pain in Smokers' on July 23.
Brief Summary: The purpose of this study is to understand whether psilocybin therapy is safe and well tolerated in improving chronic pain and increasing motivation to quit smoking for people who have chronic pain and smoke cigarettes. Psilocybin is a psychedelic drug and the active ingredient in "magic mushrooms." Psilocybin is currently being studied in clinical trials but has no current medical use in the United States. Some studies have shown that a dose of psilocybin can help people quit smoking. Other studies have shown that a dose of psilocybin may improve cert...